
Autologous serum eye drops (AS) have been considered a potential treatment for dry eye, a common condition with global implications. A review of six randomized clinical trials involving 116 participants was conducted to assess the effectiveness and safety of AS. The evidence suggests that AS may improve symptoms of dry eye after two weeks compared to saline, but certainty is low. Ocular surface outcomes were inconclusive. AS may also slightly improve Rose Bengal staining compared to saline after four weeks, but the evidence quality is very low. No significant benefits were found for other measures like corneal topography, conjunctival biopsy, quality of life, economic outcomes, or adverse events. Overall, the effectiveness of AS remains uncertain based on current data.
Like
Save
Share